NCT05100706View on ClinicalTrials.gov

Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

January 6, 2025

Study Completion Date

June 30, 2025

Conditions
Knee Arthroplasty, TotalAnesthesia, RegionalAcute Pain
Interventions
DRUG

Continuous adductor canal block (CACB)

Ropivacaine 0.2% infusion through adductor canal catheter

DRUG

Sham continuous adductor canal block (ShACB).

NaCl 0.9% infusion through adductor canal catheter

Trial Locations (1)

M5G 1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
collaborator

MOUNT SINAI HOSPITAL

OTHER

lead

University of Toronto

OTHER

NCT05100706 - Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter